Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

By Rutten-van Mölken Maureen   Oostenbrink Jan   Miravitlles Marc   Monz Brigitta  

The European Journal of Health Economics, Vol. 8, Iss. 2, 2007-06 ,pp. : 123-135

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the combination of two bronchodilators on breathlessness in patients with chronic obstructive pulmonary disease. A crossover clinical trial

By Sansores R.   Ramirez-Vanegas A.   Reddy C.   Mejia-Alfaro R.  

Archives of Medical Research, Vol. 34, Iss. 4, 2003-07 ,pp. : 292-297

Elsevier

Access to resources Recommend Favorite

Comparison of the Bronchodilating Effect of Salmeterol and Zafirlukast in Combination with That of Their Use as Single Treatments in Asthma and Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 68, Iss. 5, 2001-10 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 695-708

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Nebulized Flunisolide Combined with Salbutamol and Ipratropium Bromide in Stable Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease

By  

Respiration, Vol. 73, Iss. 5, 2006-09 ,pp. : 603-609

Karger

Access to resources Recommend Favorite